Extendicare (EXE) investor relations material

Opening remarks and agenda

• Meeting opened with land acknowledgment, introductions, and remarks from the Chair and CEO focusing on growth, care quality, and strategic direction.

• Notice of meeting and quorum confirmed, with over 25% of voting shares represented.

• Agenda included financial statements, auditor appointment, director elections, and advisory vote on executive compensation.

Financial performance review

• 2025 consolidated financial statements and auditor's report presented and approved; available online.

• Profits increased over 28% in the past year, with CEO compensation exceeding $2.6 million.

• Transformation efforts delivered strong momentum into 2026, with a resilient financial and operational foundation.

• Completion of a CAD 200 million equity private placement and a $450 million unsecured note offering strengthened financial position.

• Enhanced financial flexibility achieved through refinancing, equity raising, and strong cash flow.

Board and executive committee updates

• Nine directors, including Josh Blair and Leslee Thompson, were nominated and elected to serve until the next annual meeting.

• Donna Kingelin and Alan Torrie recognized for over a decade of board service.

• Board succession planning ensures continuity and stability, with diverse expertise across care, technology, and governance.

• Samir Manji to assume role of chair following the meeting.